In the matrigel plug and the mouse B16F10 melanoma xenograft models, ROX can significantly promote an angiogenetic effect, and shRNA targeting Vegfr2 can inhibit the promotion of ROX (Figure 4 and Figure 5). Here, KDR is linked to melanoma.